Drug Trial Radar · NCT06010329
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
66
Planned (sponsor's estimate)
Start
Dec 27, 2023
Primary completion
Dec 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Teligene USIndustry
- Sponsor type
- Industry
- First posted
- Aug 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the study will be to evaluate the efficacy of sutetinib maleate capsules in participants with locally advanced or metastatic non-small cell lung cancer NSCLC (uncommon EGFR mutations only).
Conditions
- Non-small Cell Lung Cancer
Interventions
Sutetinib Maleate CapsuleDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: Pre-dose up to approximately 32 months post-dose
Locations
24 sites in 2 countries. Site status is shown where the registry gives one.
Oncology Physicians Network Healthcare
Glendale, California · Withdrawn
University of California San Diego Moores Cancer Center
La Jolla, California · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
University Cancer & Blood Center (UCBC) - Athens
Athens, Georgia · Recruiting
Mission Cancer + Blood - Mission Cancer Foundation
Des Moines, Iowa · Recruiting
Norton Cancer Institute - Downtown
Louisville, Kentucky · Withdrawn
Northwell Health
New Hyde Park, New York · Active not recruiting
Perlmutter Cancer Center - 34th Street
New York, New York · Terminated
University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Beijing Chest Hospital
Beijing, Beijing Municipality, China · Recruiting
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China · Recruiting
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China · Recruiting
Jinan Central Hospital
Jinan, Shandong, China · Recruiting
Shanghai East Hospital
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital, Sichuan University
Chengdu, Sichuan, China · Recruiting
Qujing Central Hospital of Yunnan Province
Qujing, Yunnan, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.